General Information of Drug Off-Target (DOT) (ID: OTQ378WN)

DOT Name Cytochrome c oxidase assembly protein COX14 (COX14)
Gene Name COX14
Related Disease
Advanced cancer ( )
Neoplasm ( )
Prostate cancer ( )
Prostate carcinoma ( )
Cytochrome-c oxidase deficiency disease ( )
Mitochondrial disease ( )
UniProt ID
COX14_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF14880
Sequence
MPTGKQLADIGYKTFSTSMMLLTVYGGYLCSVRVYHYFQWRRAQRQAAEEQKTSGIM
Function
Core component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly. Requires for coordination of the early steps of cytochrome c oxidase assembly with the synthesis of MT-CO1.
KEGG Pathway
Thermogenesis (hsa04714 )
Reactome Pathway
Respiratory electron transport (R-HSA-611105 )
Cytoprotection by HMOX1 (R-HSA-9707564 )
TP53 Regulates Metabolic Genes (R-HSA-5628897 )

Molecular Interaction Atlas (MIA) of This DOT

6 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Altered Expression [1]
Neoplasm DISZKGEW Strong Altered Expression [1]
Prostate cancer DISF190Y Strong Altered Expression [1]
Prostate carcinoma DISMJPLE Strong Altered Expression [1]
Cytochrome-c oxidase deficiency disease DISK7N3G Supportive Autosomal recessive [2]
Mitochondrial disease DISKAHA3 Limited Autosomal recessive [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Cytochrome c oxidase assembly protein COX14 (COX14). [4]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Cytochrome c oxidase assembly protein COX14 (COX14). [5]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Cytochrome c oxidase assembly protein COX14 (COX14). [6]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of Cytochrome c oxidase assembly protein COX14 (COX14). [7]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Cytochrome c oxidase assembly protein COX14 (COX14). [8]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Cytochrome c oxidase assembly protein COX14 (COX14). [9]
Fluorouracil DMUM7HZ Approved Fluorouracil affects the expression of Cytochrome c oxidase assembly protein COX14 (COX14). [10]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Cytochrome c oxidase assembly protein COX14 (COX14). [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)

References

1 Identification of PCAG1 as a novel prostate cancer-associated gene.Mol Med Rep. 2013 Mar;7(3):755-60. doi: 10.3892/mmr.2012.1249. Epub 2012 Dec 24.
2 Mutations in C12orf62, a factor that couples COX I synthesis with cytochrome c oxidase assembly, cause fatal neonatal lactic acidosis. Am J Hum Genet. 2012 Jan 13;90(1):142-51. doi: 10.1016/j.ajhg.2011.11.027.
3 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
4 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
5 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
6 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
7 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
8 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
9 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
10 New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids. Arch Toxicol. 2021 Aug;95(8):2691-2718. doi: 10.1007/s00204-021-03092-2. Epub 2021 Jun 20.
11 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.